March 18, 2020
19/03/2020
March 18, 2020
Scripps Research scientists are pursuing multiple lines of research aimed at understanding and helping to mitigate the impact of the novel coronavirus behind the COVID-19 epidemic that has spread across the globe. They are tracing how the virus originated and spreads, exploring how it invades the body and how the immune system responds, and working to develop potential vaccines and medicines against the virus.
What is coronavirus?
Coronavirus is the family of viruses that causes outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), two illnesses that emerged within the last two decades. Symptoms of coronavirus infections include flu-like symptoms such as fever, cough and shortness of breath.
The virus behind the current epidemic, called SARS-CoV-2, is a previously unknown member of the coronavirus family. The epidemic, which began in the Chinese city of Wuhan, has spread to every continent but Antarctica and has sickened tens of thousands of people, resulting in several thousand deaths as of early March 2020.
How did this virus originate, and how does it spread?
Kristian Andersen, PhD, a Scripps Research genomic epidemiologist and professor in the Department of Immunology and Microbiology, is tracing the origins of the novel coronavirus genome based on public sequencing data. An expert in tracking the spread of deadly viruses (including Ebola, Lassa and Zika), Andersen launched a collaboration with institutes from around the world to analyze the virus's genome and trace its origins. The team's study, reported in Nature Medicine on March 17, quells rumors about that it was engineered in a laboratory. You can read more about the findings here.
His team is also working with colleagues across the globe to better understand how the virus is transmitting in the human population from its beginning in China to its current spread around the world.
Can we repurpose existing drugs to treat patients with COVID-19?
Scripps Research teams are testing already approved drugs and compounds with significant safety data in humans available, for activity against SARS-CoV-2. These drugs could be made available to treat coronavirus patients on a much quicker timescale than novel therapies.
Calibr, the drug development division of Scripps Research, is leveraging a unique resource, the ReFRAME drug repurposing collection. With support from the Bill & Melinda Gates Foundation, Calibr compiled ReFRAME, the world's leading collection of known drugs comprising over 14,000 compounds that have been approved by the FDA for other diseases or have been tested for human safety. Calibr also developed an open source database containing preclinical and clinical data on these compounds. Since information on the drugs' therapeutic properties and safety is known, they can be screened and rapidly advanced into the clinic.
Since its creation in 2018, ReFRAME has been distributed broadly to nonprofit collaborators for global health and used to identify repurposing opportunities for a range of diseases. When the COVID-19 outbreak began, Calibr was able to mobilize ReFRAME quickly to begin searching for existing drugs and other compounds that might be repurposed against the coronavirus.
ReFRAME is now being screened to identify compounds that can:
Prevent the virus from entering and infecting cells
Prevent the virus from replicating in cells
Augment the efficacy of antivirals such as remdesivir, which is being tested in five COVID-19 clinical trials
Since the outbreak began, Calibr has established collaborations to screen the ReFRAME library for potential coronavirus therapies with nine outside research teams, including U.S. laboratories in Maryland, Massachusetts, New York, and Texas, as well as overseas labs in the UK, Germany, Belgium and Hong Kong. Calibr is also establishing partnerships with pharmaceutical companies to screen earlier stage antiviral collections against COVID-19.
ReFRAME has been highlighted in the COVID-19 Therapeutics Accelerator launched by the Bill & Melinda Gates Foundation.
In addition to Calibr, Matthew Disney, PhD, a chemistry professor the Florida campus of Scripps Research, is also exploring compound repurposing. Disney develops potential medicines that work by precisely targeting disease-causing RNA, the protein-building machinery inside of cells. He is using his tools to identify drug-like compounds that may have activity against the novel coronavirus, which is an RNA virus.
How does the novel coronavirus interact with our immune system? Can this knowledge help us fight the virus and develop a vaccine?
Researchers in the Scripps Research laboratory of Dennis Burton, PhD, chair of the Department of Immunology and Microbiology, are studying the human immune response to SARS-CoV-2 infections. They are also working to identify potent broadly neutralizing antibodies, which might serve as the basis for vaccines or antiviral therapies against COVID-19.
The laboratory of Ian Wilson, DPhil, chair of the Department of Integrative Structural and Computational Biology at Scripps Research, is studying the differences between the virus that caused the 2002 outbreak of SARS (SARS-CoV) and the novel coronavirus (SARS-CoV-2) behind the COVID-19 pandemic. They are exploring whether antibodies produced against one coronavirus can interact with a different coronavirus.
They found that one antibody (CR3022), previously produced against SARS-CoV by the company Crucell Holland BV, binds to the receptor binding domain on the spike protein of SARS-CoV-2. Wilson's team pro
LINK: | https://www.scripps.edu/news-and-events/press-room/2020/20200318-refra... |
See more stories from scripps |
More from Scripps
20/04/2024
April 19, 2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
April 11, 2024
Scripps Research chemists devise easier new method for making a common type of building block for drugs Scientists transform simple linear amines into saturated...
06/04/2024
April 05, 2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
April 03, 2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
March 29, 2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...
07/11/2023
November 06, 2023
Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...
05/10/2023
October 04, 2023
Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...
22/09/2023
September 21, 2023
Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...
09/09/2023
September 08, 2023
Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...
07/09/2023
September 06, 2023
Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...
31/08/2023
August 30, 2023
Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...
16/08/2023
August 16, 2023
How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...
08/08/2023
August 07, 2023
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...
04/08/2023
August 03, 2023
How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...
26/07/2023
July 26, 2023
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...
23/07/2023
July 21, 2023
Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...
19/07/2023
July 19, 2023
Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...
19/07/2023
July 18, 2023
Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...
15/06/2023
June 14, 2023
Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...
13/06/2023
June 13, 2023
Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...
31/05/2023
May 31, 2023
Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...
24/05/2023
May 23, 2023
Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...
19/05/2023
May 15, 2023
Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...
19/05/2023
May 18, 2023
Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...
13/05/2023
May 12, 2023
A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...
09/05/2023
May 08, 2023
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...
28/04/2023
April 27, 2023
Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...
22/04/2023
April 21, 2023
How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...
21/04/2023
April 20, 2023
Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...
20/04/2023
April 19, 2023
Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...
18/04/2023
April 17, 2023
Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...
07/03/2023
March 06, 2023
How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...
02/03/2023
March 01, 2023
Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...
28/02/2023
February 28, 2023
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...
28/02/2023
February 27, 2023
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...